Also listed on International - Drug - Development - Biotech, an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Dec 15, 2025 (Morgan Stanley Senior Funding, Inc.).
Term ends Oct 31, 2033 · High confidence
20-year base term ends Jul 9, 2033
Held by Genmab B.V.
Filed Jan 6, 2015 as application 14/413,194 · Granted Apr 4, 2017
Base term plus 114 days of patent term adjustment (USPTO delay)
Today
2013
2033
Clock starts
Jul 9, 2013
Jul 9, 2013
Term ends
Oct 31, 2033
Oct 31, 2033
Granted
Apr 4, 2017
Apr 4, 2017
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
114
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 114 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 9, 2013, when application PCT/EP2013/064466, the earliest non-provisional in its chain, was filed (this one was filed Jan 6, 2015) | Jul 9, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +114 days, USPTO patent term adjustment record | Oct 31, 2033 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 31, 2033 | High confidence |
This family
| US 9,611,327 | this patent Oct 2033 | Oct 2033 |
| US 10,647,774 | In force Apr 2034 | Apr 2034 |
| Application 16/841,306 | Abandoned not computed | not computed |
| Application 18/461,910 | Pending not computed | not computed |
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 19, 2015 Reel 34983, frame 49 | Vermot-desroches, Claudine Brigitte Fernande; Subiger, Olivier Frédéric; Bourdin, Laurence Françoise Jeanne-Marie | International - Drug - Development - Biotech | Assignment of Assignor's Interest |
| Feb 3, 2016 Reel 37651, frame 945 | International-Drug-Development-Biotech | Genmab Holding B.V. | Assignment of Assignor's Interest |
| Feb 17, 2017 Reel 41289, frame 610 | Genmab Holding B.V. | Genmab B.V. | Assignment of Assignor's Interest |
| Dec 15, 2025 Reel 73933, frame 597 | Genmab A/S; Genmab B.V.; Genmab Holding B.V. | Morgan Stanley Senior Funding, Inc. | Security Interest |
| Dec 15, 2025 Reel 73949, frame 722 | Genmab A/S; Genmab B.V.; Genmab Holding B.V. | Wilmington Trust, National Association | Notice of Grant of Security Interest in Patents |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Oct 2033
Term ends Oct 31, 2033. Maintenance fees still fall due before then
Note
The 114 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
8
later US patents cite this one
That is above the median of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.